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THE USEFULNESS OF ADENOSINE DEAMINASE IN THE DIAGNOSIS OF TUBERCULOUS
PERICARDITIS
Felipe Francisco TUON(1), Vivian Iida da SILVA(1), Gisele M. Duboc de ALMEIDA(2), Leila ANTONANGELO(2) & Yeh Li HO(1)
SUMMARY
The objective of this study was to evaluate the adenosine deaminase (ADA) activity usefulness in the diagnosis of tuberculous
pericarditis (TP), comparing its value with pericardial effusions (PE) caused by other pericardial diseases. A retrospective case-
control study was conducted with nine cases of TP and 39 other than TP diseases (12 neoplastic, 11 septic and 16 unknown origin).
Every patient included in this study had PE samples submitted to ADA activity measures and microbiological analysis, and then
had pericardial tissue samples submitted to microbiological and histopathological examination. Considering the value of 40 U/L
as the cut-off for the diagnosis of TP, the specificity and sensitivity were respectively of 72% and 89%. The specificity of ADA
activity for the TP was best applied in the differential diagnosis from PE of unknown origin. The present study demonstrates the
clinical value of the measurement of ADA activity in PE in the diagnosis of TP.
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INTRODUCTION
Adenosine deaminase (ADA) is an enzyme present in a great
number of plants and animals, found from simple invertebrates to
human beings. It is an important enzyme that catalyzes the deamination
of adenosine and deoxyadenosine into their respective inosine
nucleosides2,10. This conversion is an initial step of a series of reactions
responsible for lymphocytes proliferation and differentiation. Therefore,
ADA is considered an indicator of cellular immunity and fundamental
for the differentiation of lymphocytes5. In humans, the lack of this
enzyme results in severe lymphopenia and immunodeficiency, bringing
the risk of an early death for the affected individuals4.
ADA is found in several human diseases, lymphocytic effusions,
including those consequent of tuberculosis, neoplasm and some acute
viral infections. This suggests that a high ADA activity is indirectly
related to the subsets of T cell lymphocytes involved in the inflammatory
response18.
Macrophages also synthesize ADA, and it is the isoenzyme ADA-
2 the one produced in greater amount by them. This explains why
ADA activity can be high in acute effusions, including that one in
which cellular differentiation pattern is predominantly neutrophilic22.
It is important to remember that ADA is present in all mammalian
cells and, despite a number of studies performed to date, the
physiological role that it plays in the different tissues is not yet clear8.
Tuberculous pericarditis (TP) is a rare form of extrapulmonary
tuberculosis frequently associated with high mortality and severe short
or long term complications29. This is especially true when the diagnosis
and the correct treatment of the disease is delayed7. Survival time
without treatment is approximately four months. Even when the patients
receive treatment, the mortality rate ranges from 3 up to 40%33. The
main complications of TP are: constrictive pericarditis with or without
restrictive hearth failure; cardiac tamponade, a most frequent cause of
death if not detected and properly managed12. The lack of specificity
of TP symptoms makes this condition hard to diagnose7. The tuberculin
skin test (TST) and thorax radiography are associated with a low positive
predictive value of TP25,30. On the other hand, transthoracic
echocardiogram is a useful test to detect and quantify pericardial
effusion. It is in addition a valuable tool to guide the pericardiocentesis,
which can also be performed by videothoracoscopy23,31.
Pericardial effusion (PE) in TP is characterized by a lymphocytic
exudate, but occasionally it can be either neutrophilic or mixed26. Acid
fast bacilli stains on PE sediment are usually negative and culture
sensitivity is no greater than 50%3,6,14. Due to the difficulty of
establishing the diagnosis of TP using clinical, radiological, cytological
or even microbiologic evaluation, attempts to correlate TP diagnosis
with other markers have been pursued5. The analysis of ADA activity
is one of the most studied possibilities and should be highlighted as an
accurate measurement method for values greater than 40 U/L9,17,21,24.
Unfortunately, as far as we know, there is no knowledge about the
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value of ADA activity in a moderate to high-incidence region of
tuberculosis (84-50 per 100,000 pop.).
The objective of this study was to evaluate the ADA activity
usefulness in the diagnosis of tuberculous pericarditis, comparing its
value in pericardial effusions caused by TP and those caused by other
conditions in a moderate to high-incidence region of tuberculosis.
MATERIAL AND METHODS
A retrospective diagnostic test study was conducted in the Clinical
Hospital from Medical School of University of São Paulo. A database
search of cases from January 2000 to December 2005 was performed
in the Cavity Fluids Laboratory and Clinical Microbiology Laboratory,
where all the specimens from pericardial effusions were submitted to
ADA activity measurement and microbiological analysis. The
histopathological material obtained from these patients was reviewed.
Every patient included in the study had PE samples submitted to ADA
activity measures and to microbiological analysis, and they also had
pericardial tissue samples submitted to microbiological and
histopathological examination.
The diagnosis of TP was established when at least one of the
following criteria was present: (1) positive culture for Mycobacterium
tuberculosis in pericardial tissue or effusion; (2) presence of
granulomas containing alcohol-acid resistance bacilli (AFB) in
histopathological analysis of pericardium; or (3) presence of
granuloma in pericardial tissue associated with active tuberculosis
at another site, as previously described criteria7,32,33. The control group
(non-tuberculous pericardial effusions) was formed with those patients
that had pericardial effusions of other etiology. Pericardial effusions
were defined as non-tuberculous when the following criteria were
fulfilled: no histological evidence of tuberculosis was found, and
negative effusion/sputum stain and culture for tuberculosis; or a
definite alternative diagnosis was established.
ADA activity (U/L) was determined in every pericardial fluid
specimen according to the method described by GIUSTI22. The cut-off
value for ADA activity considered adequate to presume the diagnosis
of TP was established as 40 U/L, as previously determined by several
articles about this issue and meta-analysis9,17,21,24,26,32.
The cases without microbiological and histopathological
examinations were excluded from the analysis.
The pericardial fluid’s cytology was analyzed and the total
cellularity and percentages of neutrophils and lymphocytes were
compared among the different pericardial diseases.
Clinical, histopathological, microbiological and ADA activity
information were recorded in Epi Info 6.0 (CDC, Atlanta). The
statistical analysis of ADA activity was performed comparing its mean
values according to the various PE etiological factors with t Student
test. The means ± SD (standard deviation) were considered significantly
different when a p value < 0.05 was found. The usefulness of
determining ADA activity as a diagnostic tool for TP was evaluated by
calculating its sensitivity, specificity, positive predictive value (PPV)
and negative predictive value (NPV) expressed as percentage.
Receiver-operating-characteristics (ROC) curve analysis helped to
decide the optimal cutoff point for ADA activity (continuous variable)
based on their highest diagnostic accuracy. Data were analyzed by
using the SPSS statistical package, version 10.0 (SPSS, Inc, Chicago,
Illinois).
RESULTS
Eighty eight cases from 2000 to 2005 in which ADA activity on
PE was measured were identified. From these, 71 specimens were
submitted to microbiological analysis. Forty eight specimens were
submitted to histopathological evaluation. Eight of these cases had a
microbiological test positive for TP (AFB smear or culture positive
for M. tuberculosis), one case was a granuloma found without positive
culture or AFB smear. Since in this case the presence of M. tuberculosis
was verified in the patient’s sputum, the diagnosis of TP was considered
positive.
Samples that did not fulfill the diagnostic criteria for TP but were
submitted to histopathological examination were selected to form the
control group, amounting a total of 39 cases. These included malignant
effusions (12 cases), septic pericarditis (11 cases) and some defined as
of unknown origin (16 cases).
The patients mean age in the TP group was of 42.5 (25 - 67) years
old and 55.5% of them were male. In the control group the mean age
was of 43.8 (15 - 69) and 51% of the patients were male (p = 0.78).
The mean ADA activity value in the TP group was of 180.2 ± 121.9
and of 47.3 ± 76.6 in the control group (p < 0.05) (Table 1). Considering
the value of 40 U/L as the cut-off for the diagnosis of TP, the specificity
and sensitivity were respectively of 72% and 89%. When stratified
according to the group control diagnosis, the specificity of ADA activity
for the tuberculosis diagnosis showed different values (Table 2). ADA
activity values were best applied in the differentiation of a TP pericardial
effusion and a PE of unknown origin, although without statistical
significance. In this group, the specificity was 94% and the predictive
value positive 89%. The positive and negative likelihood ratio (LR+
and LR-) were 3.15 and 0.15, respectively.
The levels of ADA activity in neoplasm and bacterial pericarditis
are showed on Table 3. Breast and lung cancer were neoplasms with
high level of ADA activity, only one case of lymphoma showed
increased level of ADA activity from three cases. There was association
Table 1
ADA activity on pericardial tuberculosis and other causes of pericardial
effusion
Cause of n ADA activity CI p value
pericarditis (mean ± SD)
Tuberculosis 9 180.2 ± 121.9 (100.9-259)
Non Tuberculosis 39 47.3 ± 76.6 (23.3-71.4) < 0 .05
Neoplasm 12 29.6 ± 19.9 (18.3-40.4)  0.09
Septic 11 104.2 ± 128.1 (28.5-179.9) 0.19
Unknown origin 16 21.6 ± 17.3 (13.1-30.0) 0.08
CI: Confidence interval; SD: Standard deviation.
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between etiological agent and ADA activity levels. The cytological
analysis of TP samples showed a neutrophilic predominance and there
was a significant difference when compared to PE of unknown origin
or neoplastic PE. There was no difference between bacterial pericarditis
and TP when comparing the cytological study. The pericardial fluid
cellularity was not defined as characteristic of any of the diseases (Table
4). The area under curve (AUC) of ROC analysis was of 0.85 (Fig. 1).
This is a satisfying number and it permitted the calculation of the
ideal ADA activity cut-off value in the diagnosis of TP. The ideal cut-
off of our study was 39.95 U/L.
DISCUSSION
Tuberculous pericarditis is a rare clinical condition in developed
countries. On the other hand, the number of TP cases in developing
countries is underestimated due to difficulties in the diagnosis, which
require high cost procedures and laboratorial exams not readily available
in most of health services. In these countries, TP is the leading cause
of PE among pericardial diseases, responsible for more than 70% of
the cases26.
Our study confirmed typical aspects of ADA activity in the TP, the
results being consistent with the data found in the literature9. The mean
value of ADA activity in TP pericardial effusions was significantly
higher than in those caused by non-tuberculous pericarditis. However,
this difference was not sustained when comparing each specific cause
of pericarditis, since the number of patients in the various groups was
limited. The ideal number of TP cases for the study’s statistical analysis
was determined calculating the sample size. This sample estimative
took into consideration errors type I and II and the minimal number of
Table 2
Comparison of tuberculous pericarditis effusion ADA activity and other diagnosis
Total ADA ADA Sens Spec PPV NPV Accuracy
> 40 < 40
Tuberculosis 9 8 1
Non tuberculosis 39 11 28
Total 48 19 39 89 72 42 96 75
Tuberculosis 9 8 1
Neoplasia 12 3 9
Total 21 11 10 89 75 73 90 81
Tuberculosis 9 8 1
Septic 11 7 4
Total 20 15 5 89 36 53 80 60
Tuberculosis 9 8 1
Unknown origin 16 1 15
Total 25 9 16 89 94 89 94 92
Sens: Sensitivity; Spec: Specificity; PPV: Positive predictive value; NPV: Negative predictive value.
Table 3
Values of ADA activity and correspondent neoplasm or etiologic agent in septic pericarditis
ADA Value Primary neoplasm ADA value Etiology of septic pericarditis
(U/L) (U/L)
22.9 Lung 332 H. influenzae
62.5 Breast 77.8 Gram positive coccus on tissue
34.9 Lymphoma 47.9 Staphylococcus sp.
56.8 Lymphoma 27 Staphylococcus sp.
33.5 Neuroendocrine 5.6 Staphylococcus aureus
10.8 Lung 147 Acinetobacter baumannii
59.1 Lung 9.6 Pseudomonas aeruginosa
17 Lung 3.5 Pseudomonas aeruginosa
14.7 Lymphoma 54 Staphylococcus sp.
12.6 Adamantinoma 76 Staphylococcus aureus
7.1 Metastatic unknown 366 Gram negative bacillus
23 Lung
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cases found to be necessary was eight15. The ideal number of control
cases was three times bigger. Since the number of identified TP cases
was nine and the total number of non-tuberculous pericarditis was of
33 cases, the proportion was satisfactory. Nevertheless, the comparison
of the different subtypes of pericarditis could not be properly assessed
with these numbers. Furthermore, calculating the mean value of ADA
activity was not the best approach to evaluate the true significance of
this laboratory assay due to total number of cases in each etiology.
The ADA activity sensitivity for TP in our study was similar to
that found in other studies9,17,21,24,25. Only recently, a meta-analysis
evaluating ADA activity levels in TP obtained a mean sensitivity of
88% (CI 82-91%)32. Therefore, the result of 89% that we originated
indicates that measuring ADA activity in PE is, indeed, useful as a
screening investigation for TP.
The same conclusion cannot be reached when analyzing the
specificity value we verified, which was of 72%. This result was
higher in PE of unknown origin and lower in septic PE. It was a
surprise to find such a high level of ADA activity in septic PE, similar
to the numbers ascribed to TP. It is true that this pattern has been
observed in other studies9,17,25, but the number of septic pericarditis
cases they brought to attention was always limited and did not weight
in the calculus of their control groups’ mean ADA activity. The
cellularity analysis of the PE samples showed the same pattern in TP
and septic PE, a neutrophilic predominance. This aspect of our study
has not been previously reported in reference to TP. In truth, every
study up until now associates a lymphocytic predominance with the
condition.
This test will not confirm with certainty the TP diagnosis, rather it
corroborates to the diagnosis substantially, independent of the predictive
pre-test values, which was not evaluated. For this reason we calculated
the LR+ and LR-. With these values, the clinician can associate a pre-
test probability with ADA activity and verify how much the ADA
activity results could rise the probability of TP11. The opposite is also
true, since the specificity of ADA activity was high. Although ADA
activity could be used as a sole method of diagnosis, cultures should
be available due to the increasing incidence of multidrug resistant
tuberculosis27.
The difficulty to establish the etiologic diagnosis of TP fosters the
search of a reliable, quick and affordable diagnostic test for this illness.
Several studies have demonstrated the importance of the cytological
pattern, nucleic acid amplification (NAA), lysozyme and γ-interferon
among others, but the most studied factor so far is the ADA activity1,21,24.
Despite the existence of some studies concerning ADA activity and
TP, few publications have yet compared ADA activity in TP and septic
pericarditis. In Brazil, FRODE & MEDEIROS, using an animal model
of pleurisy, demonstrated the increased level of ADA activity in early
inflammation and its coincidence with the neutrophils raise13. In
addition, other studies have demonstrated that high levels of ADA
activity can be found in neutrophilic effusions, including those caused
by tuberculosis16,19. Further studies on the microenvironment of
pericardium and inflammation are needed to explain this finding.
In our study, the neoplasm cases did not have significantly increased
levels of ADA activity, not even when analyzing its specific subgroups.
The values of sensitivity and specificity were acceptable.
Table 4
Cytology of various pericarditis and comparison with tuberculous pericarditis
Cause of pericarditis n Total cellularity N L p value
(Mean of cell/mL) (% ± SD) (% ± SD)
Tuberculosis 9 2210 81 ± 18 18 ± 19
Non Tuberculosis 39 2738.9 36 ± 33 63 ± 33 < 0.05
Neoplasm 12 2805.8 19 ± 16 80 ± 22 < 0.05
Septic 11 5347.7 59 ± 37 39 ± 37 0.19
Unknown origin 16 707.6 30 ± 31 55 ± 31 < 0.05
N: Neutrophils; L: Lymphocytes.
Fig. 1 - Curve ROC graph for ADA activity in pericardial effusion to
diagnosis of tuberculous pericarditis.
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The study’s ideal cut-off, calculated using the AUC of ROC curve,
was identical to the one used in the literature. This value allows, with
a reasonable accuracy, the establishment of the diagnosis of TP.
The present study was able to demonstrate that ADA activity has
a high sensitivity for TP, and thus prove that it is a useful tool to
achieve this diagnosis. Nonetheless, it is not a reliable method to
differentiate TP and septic pericarditis. Hence it substantially
corroborates for the TP diagnosis, independently of predictive pre-
test values, when septic pericarditis is not a possibility. Given that
the cut-off of 40 U/L can be used with security and the sensitivity
values found in our study were high, we conclude that it is feasible
to use ADA activity measures to diagnose TP. Moreover, when septic
pericarditis is excluded, it can guide physicians in starting
antituberculous treatment. In contrast, the specificity we found was
not so high, not helping in the exclusion of the diagnosis when patients
present with normal values of ADA activity.
When the test is applied in populations with high prevalence of the
disease, the positive predictive value increases due to lower proportion
of false-positive results. Therefore, a increased ADA level in a PE of
patient living in a country with high prevalence of TP (developing
countries) will be more reliable than one performed in a developed
country. In countries with low prevalence of TP, a decreased ADA level
will be more reliable than an increased level, because the number of
true-negative is high. The positive predictive value increases and
decreases in accordance with the prevalence of the target condition in
the screened population. Thus, unlike sensitivity and specificity, the
positive predictive value is not a constant performance characteristic
of a screening test. If the target condition is sufficiently rare in the
screened population, even tests with excellent sensitivity and specificity
can have low positive predictive value, generating more false-positive
than true-positive results20.
Adenosine deaminase activity is a cost-effective test in the diagnosis
of pleural tuberculosis. Cost-effectivity study should be performed in
this group of patients with TP, and probably it will show a similar
result, once the sensitivity and specificity are coincident28.
In summary, the present study demonstrates the clinical value of
measurement of ADA activity in PE, a simple and affordable test in a
population of moderate to high-incidence region of tuberculosis in the
diagnosis of pericardial tuberculosis.
RESUMO
O uso da adenosina deaminase no diagnóstico da tuberculose
pericárdica
O objetivo deste estudo foi avaliar a atividade da adenosina
deaminase (ADA) como auxiliar no diagnóstico da tuberculose
pericárdica (TP), comparando o seu valor no derrame pericárdico com
outras doenças pericárdicas. Um estudo retrospectivo tipo caso-controle
foi conduzido com nove casos de TP e 39 pacientes com outras doenças
pericárdicas (12 neoplasias, 11 pericardites bacterianas e 16 pericardites
de etiologia indeterminada). Cada paciente incluído no estudo teve
sua amostra de tecido pericárdico encaminhada para estudo
microbiológico e histopatológico. Considerando o valor de 40 U/L
como corte para o diagnóstico de TP, a especificidade e sensibilidade
foram respectivamente 72 e 89%. A especificidade da atividade de
ADA para a TP foi melhor aplicada no diagnóstico diferencial entre
derrame pericárdico de origem indeterminada. O presente estudo
demonstrou o valor clínico da mensuração da atividade de ADA no
diagnóstico de TP.
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